Jinhong Zhu, Ph.D. - Publications

Affiliations: 
2009 University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Biomedical Engineering, Molecular Biology

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Li L, Zhu J, Lu T, Liu W, Tang J, Zhang J, Wang Y, Li Y, Li S, Zhou H, Xia H, He J, Cheng J. Association of miR-34b/c rs4938723 and TP53 Arg72Pro Polymorphisms with Neuroblastoma Susceptibility: Evidence from Seven Centers. Translational Oncology. 12: 1282-1288. PMID 31325764 DOI: 10.1016/j.tranon.2019.06.008  0.4
2019 Wang X, Yin H, Zhang L, Zheng D, Yang Y, Zhang J, Jiang H, Ling X, Xin Y, Liang H, Fang C, Ma J, Zhu J. The construction and analysis of the aberrant lncRNA-miRNA-mRNA network in non-small cell lung cancer. Journal of Thoracic Disease. 11: 1772-1778. PMID 31285869 DOI: 10.21037/jtd.2019.05.69  0.4
2017 Xiong SW, Ma J, Feng F, Fu W, Shu SR, Ma T, Wu C, Liu GC, Zhu J. Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis. Oncotarget. 8: 25300-25309. PMID 28445975 DOI: 10.18632/oncotarget.15811  0.4
2016 Zhu J, Ma J, Wang X, Ma T, Zhang S, Wang W, Zhou X, Shi J. High Expression of PHGDH Predicts Poor Prognosis in Non-Small Cell Lung Cancer. Translational Oncology. 9: 592-599. PMID 27916294 DOI: 10.1016/j.tranon.2016.08.003  0.4
2015 Jiang J, Sun X, Zhu J, Ma J, Luan J, Liu S. [Genetic characteristics and research progress of targeted therapy in squamous cell carcinoma]. Zhongguo Fei Ai Za Zhi = Chinese Journal of Lung Cancer. 18: 172-8. PMID 25800575 DOI: 10.3779/j.issn.1009-3419.2015.03.08  0.4
2014 Zhu J, Hua RX, Jiang J, Zhao LQ, Sun X, Luan J, Lang Y, Sun Y, Shang K, Peng S, Ma J. Association studies of ERCC1 polymorphisms with lung cancer susceptibility: a systematic review and meta-analysis. Plos One. 9: e97616. PMID 24841208 DOI: 10.1371/journal.pone.0097616  0.4
2011 Ma J, Holden K, Zhu J, Pan H, Li Y. The application of three-dimensional collagen-scaffolds seeded with myoblasts to repair skeletal muscle defects. Journal of Biomedicine & Biotechnology. 2011: 812135. PMID 22203786 DOI: 10.1155/2011/812135  0.4
2011 Zhu J, Li Y, Lu A, Gharaibeh B, Ma J, Kobayashi T, Quintero AJ, Huard J. Follistatin improves skeletal muscle healing after injury and disease through an interaction with muscle regeneration, angiogenesis, and fibrosis. The American Journal of Pathology. 179: 915-30. PMID 21689628 DOI: 10.1016/j.ajpath.2011.04.008  0.4
2008 Nozaki M, Li Y, Zhu J, Ambrosio F, Uehara K, Fu FH, Huard J. Improved muscle healing after contusion injury by the inhibitory effect of suramin on myostatin, a negative regulator of muscle growth. The American Journal of Sports Medicine. 36: 2354-62. PMID 18725651 DOI: 10.1177/0363546508322886  0.4
2008 Shen W, Li Y, Zhu J, Schwendener R, Huard J. Interaction between macrophages, TGF-beta1, and the COX-2 pathway during the inflammatory phase of skeletal muscle healing after injury. Journal of Cellular Physiology. 214: 405-12. PMID 17657727 DOI: 10.1002/jcp.21212  0.4
2007 Li Y, Li J, Zhu J, Sun B, Branca M, Tang Y, Foster W, Xiao X, Huard J. Decorin gene transfer promotes muscle cell differentiation and muscle regeneration. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 1616-22. PMID 17609657 DOI: 10.1038/sj.mt.6300250  0.4
2007 Zhu J, Li Y, Shen W, Qiao C, Ambrosio F, Lavasani M, Nozaki M, Branca MF, Huard J. Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis. The Journal of Biological Chemistry. 282: 25852-63. PMID 17597062 DOI: 10.1074/jbc.M704146200  0.4
Show low-probability matches.